NCT06190119

Brief Summary

The purpose of this study is to observe whether there are differences in adipokines in the aqueous humor between patients with primary open-angle glaucoma (POAG) and healthy controls

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 8, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2023

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

January 5, 2024

Status Verified

December 1, 2023

Enrollment Period

3 months

First QC Date

December 19, 2023

Last Update Submit

December 19, 2023

Conditions

Keywords

Glaucoma;Adipokines;Neuroinflammation

Outcome Measures

Primary Outcomes (1)

  • Concentration of adipokines in aqueous humor

    Aqueous humor samples were assessed for adipokines and inflammatory cytokines by Luminex bead-based multiplex array

    Cross-sectional baseline

Study Arms (2)

POAG Group

POAG patients who underwent filtering surgery, cataract surgery or MIGS.

Other: none intervention

Control Group

Healthy patients who underwent cataract surgery.

Other: none intervention

Interventions

This study has no intervention

Control GroupPOAG Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

POAG group and Control group are recruited from people who underwnt anti-glaucoma surgery and cataract surgery.

You may qualify if:

  • Patients aged 18 years or older, diagnosed with primary open-angle glaucoma (POAG) and healthy controls (who underwent cataract surgery).

You may not qualify if:

  • Other Ocular Diseases: Patients with concurrent ocular diseases such as macular degeneration, retinal detachment, etc., are excluded.
  • Ocular Surgery History: individuals who have undergone intraocular or laser surgery within the past 6 months, except for uncomplicated cataract surgery.
  • History of Ocular Trauma or Inflammation
  • Systemic Diseases or Mental Disorders: Patients with systemic diseases(e.g., diabetes, rheumatoid arthritis) and those with mental disorders are excluded.
  • Pregnancy or Lactation: Females who are pregnant or lactating are excluded.
  • Presence of any retinal or optic nerve disease other than glaucoma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hosipital

Beijing, Beijing Municipality, 100191, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

aqueous humor

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Chun Zhang, Ph.D.

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ziyao Xia, M.D.

CONTACT

Chun Zhang, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2023

First Posted

January 5, 2024

Study Start

October 8, 2023

Primary Completion

December 31, 2023

Study Completion

April 1, 2024

Last Updated

January 5, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations